Acadian Asset Management vs Cohen & Steers
AAMI and CNS side by side, both in services allied with the exchange of securities. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AAMI and CNS compare
Acadian Asset Management and Cohen & Steers are about the same size, with market caps of $3.5B and $3.7B.
On earnings, Cohen & Steers is cheaper: it trades at 22.3× trailing earnings, against 28.5× for Acadian Asset Management.
Acadian Asset Management grew revenue faster over the last twelve months (27.9% versus 8.6% for Cohen & Steers).
Cohen & Steers keeps more of each dollar of sales as profit, with a net margin of 28.2% compared with 17.0% at Acadian Asset Management.
Both pay dividends: Acadian Asset Management yields 0.32% and Cohen & Steers 2.8%.
Cohen & Steers scores higher on the StockData Score (13 against 7 for Acadian Asset Management), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AAMI | CNS |
|---|---|---|
| Size and price | ||
| Market cap | $3.5B | $3.7B |
| Share price | $97.22 | $72.72 |
| Change, 1 year | 115% | 8.6% |
| Change, 5 years | 220% | −26.1% |
| Beta (5Y) | 1.22 | 0.98 |
| Employees | 396 | 411 |
| StockData Score | ||
| Total score | 7 | 13 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 3 (better) | 0 |
| Performance score | 1 | 5 (better) |
| Health score | 2 | 5 (better) |
| Dividend score | 1 | 2 (better) |
| Valuation | ||
| P/E | 28.5× | 22.3× (better) |
| P/S | 4.8× (better) | 6.2× |
| P/B | – | 6.2× |
| EV/EBITDA | 18.0× (better) | 18.3× |
| Fair value | $56.21 | $66.71 |
| Margin of safety | −73.0% | −9.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 27.9% (better) | 8.6% |
| Revenue growth, 5Y average | 2.4% | 5.4% (better) |
| Net income growth (TTM) | 38.7% (better) | 2.8% |
| EPS growth (TTM) | 43.9% (better) | 2.2% |
| EPS growth, 5Y average | −8.7% | 13.6% (better) |
| Profitability | ||
| Operating margin | 25.5% | 32.4% (better) |
| Net margin | 17.0% | 28.2% (better) |
| Return on equity | – | 29.2% |
| Return on invested capital | – | 30.9% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | 10.5× | – |
| Altman Z-score | 4.43 | 10.87 (better) |
| Piotroski F-score | 3 (better) | 2 |
| Dividends and buybacks | ||
| Dividend yield | 0.32% | 2.8% (better) |
| Payout ratio | – | 80.2% |
| Years of dividend growth | 0 | 3 (better) |
| Dividend growth, 5Y average | −21.0% | −0.63% (better) |
| Buyback yield | – | 0.51% |
| Shareholder yield | 0.32% | 3.3% (better) |
| Ownership | ||
| Held by institutions | 101% | 56.6% |
| Held by insiders | 91.7% | 46.2% |
| Insider net buying, 12 months | −$158M | −$2.5M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 55.4% | 7.3% |
Go deeper
- AAMI stock overview
- AAMI income statement
- AAMI valuation and score
- CNS stock overview
- CNS income statement
- CNS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.